US FDA approves first at-home device for depression
By Kamal Choudhury Dec 11 (Reuters) – The U.S. Food and Drug Administration has approved Flow Neuroscience’s at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that can cause side effects with long-term use, the company said on Thursday. Depression rates in the U.S. have surged 60% over the past decade, …
US FDA approves first at-home device for depression Read More »










